CGEM – cullinan therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday? [Yahoo! Finance]
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024
EGFR Inhibitor Market to Accelerate Substantially During the Study Period (2020–2034) | DelveInsight [Yahoo! Finance]
Cullinan Oncology, Inc. (NASDAQ: CGEM) had its price target raised by analysts at Jonestrading from $22.00 to $26.00. They now have a "buy" rating on the stock.
Cullinan Oncology, Inc. (NASDAQ: CGEM) had its price target lowered by analysts at HC Wainwright from $34.00 to $29.00. They now have a "buy" rating on the stock.
Form SC 13G Cullinan Therapeutics, Filed by: Flynn James E
Form 8-K Cullinan Therapeutics, For: Apr 15
Form 3 Cullinan Oncology, Inc. For: Mar 29 Filed by: Nguyen Nate
Form S-8 Cullinan Oncology, Inc.
Form 10-K Cullinan Oncology, Inc. For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.